Loading
BI
BioAmber Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Wall Kenneth W., was filed 04 Dec 2017.
BioAmber Inc.: what insiders have been doing
BioAmber Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for BioAmber Inc. The previous disclosure was published on 4 December 2017.
The full history, which starts in 2016, counts 22 purchases against no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€346,595
22 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Revenue13.3M
Gross profit-393k-3% margin
Net income-87.5M-656.8% margin
Last declaration on 4 December 2017
Declarations22 total
40,000 shares@ US$0.4313.8% of flowCommon StockSEC:0000899243-17-027875:0
Canonical exit: 28 Feb 2018 (T+90)
10,000 shares@ US$0.47530.9% of flowCommon StockSEC:0001209191-17-049779:0
Canonical exit: 16 Nov 2017 (T+90)
13,333 sharesCommon StockSEC:0001209191-17-049136:0
Canonical exit: 13 Nov 2017 (T+90)
26,666 sharesCommon StockSEC:0001209191-17-049129:0
Canonical exit: 13 Nov 2017 (T+90)
40,000 sharesCommon StockSEC:0001209191-17-049131:0
Canonical exit: 13 Nov 2017 (T+90)
13,333 sharesCommon StockSEC:0001209191-17-049137:0
Canonical exit: 13 Nov 2017 (T+90)
40,000 sharesCommon StockSEC:0001209191-17-049243:0
Canonical exit: 13 Nov 2017 (T+90)
20,000 sharesCommon StockSEC:0001209191-17-049135:0
Canonical exit: 13 Nov 2017 (T+90)
13,333 sharesCommon StockSEC:0001209191-17-049130:0
Canonical exit: 13 Nov 2017 (T+90)
133,333 sharesCommon StockSEC:0001209191-17-049138:0
Canonical exit: 13 Nov 2017 (T+90)
13,333 sharesCommon StockSEC:0001209191-17-049132:0
Canonical exit: 13 Nov 2017 (T+90)
15,000 shares@ US$0.5349100.0% of flowCommon StockSEC:0001209191-17-048572:0
Canonical exit: 7 Nov 2017 (T+90)
25,000 shares@ US$3.87100.0% of flowCommon StockSEC:0001209191-16-149543:0
Canonical exit: 7 Feb 2017 (T+90)
10,000 shares@ US$3.8432.9% of flowCommon StockSEC:0001209191-16-149412:0
Canonical exit: 6 Feb 2017 (T+90)
1,000 shares@ US$3.693.1% of flowCommon StockSEC:0000899243-16-021025:0
Canonical exit: 22 Aug 2016 (T+90)
12,100 shares@ US$3.5436.2% of flowCommon StockSEC:0001209191-16-123084:0
Canonical exit: 18 Aug 2016 (T+90)
8,915 shares@ US$3.7027.8% of flowCommon StockSEC:0001209191-16-123084:1
Canonical exit: 21 Aug 2016 (T+90)
10,000 shares@ US$3.22100.0% of flowCommon StockSEC:0001209191-16-119216:0
Canonical exit: 9 Aug 2016 (T+90)
13,227 shares@ US$3.1134.4% of flowCommon StockSEC:0001209191-16-119196:0
Canonical exit: 7 Aug 2016 (T+90)
2,000 shares@ US$3.4746.4% of flowCommon StockSEC:0001209191-16-118463:0
Canonical exit: 3 Aug 2016 (T+90)
1,000 shares@ US$3.3822.6% of flowCommon StockSEC:0001209191-16-118463:1
Canonical exit: 4 Aug 2016 (T+90)
10,000 shares@ US$6.0651.8% of flowCommon StockSEC:0001209191-16-099319:0
Canonical exit: 10 Nov 2015 (T+90)
22 of 22 declarations
About BioAmber Inc.
BioAmber Inc. is a company focused on producing renewable chemicals from biological resources. It aims to develop sustainable solutions for the chemical industry.
